Show simple item record

dc.contributor.authorMerriel, SWD
dc.date.accessioned2020-04-24T11:59:06Z
dc.date.issued2020-01-27
dc.description.abstractAn increasing number of men diagnosed with localised prostate cancer has been accompanied by more men being considered for active surveillance as a management option. Here the author provides an update on recent developments in active surveillance and changes to NICE guidance.en_GB
dc.identifier.citationVol. 11, No. 1, pp. 8-11en_GB
dc.identifier.doi10.1002/tre.727
dc.identifier.urihttp://hdl.handle.net/10871/120788
dc.language.isoenen_GB
dc.publisherWileyen_GB
dc.rights.embargoreasonUnder embargo until 27 January 2021 in compliance with publisher policy
dc.rightsCopyright © 2020 John Wiley & Sonsen_GB
dc.titleActive surveillance for prostate cancer: an updateen_GB
dc.typeArticleen_GB
dc.date.available2020-04-24T11:59:06Z
dc.identifier.issn2044-3730
dc.descriptionThis is the author accepted manuscript. The final version is available from Wiley via the DOI in this record. en_GB
dc.identifier.eissn2044-3749
dc.identifier.journalTrends in Urology and Men’s Healthen_GB
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_GB
dcterms.dateAccepted2019-06-18
rioxxterms.versionVoRen_GB
rioxxterms.licenseref.startdate2019-06-18
rioxxterms.typeJournal Article/Reviewen_GB
refterms.dateFCD2020-04-24T11:09:09Z
refterms.versionFCDAM
refterms.dateFOA2020-04-24T11:59:10Z
refterms.panelAen_GB


Files in this item

This item appears in the following Collection(s)

Show simple item record